Multimodal iron oxide nanoparticles for breast cancer theranostics and clinical translation: From bench to bedside

Key Points

• Nanoparticles show potential for improving both diagnosis and treatment in breast cancer.
• Key evidence is the use of iron oxide nanoparticles, enhancing theranostic capabilities in a clinical setting.
• Assessment focused on the efficacy of multimodal imaging and therapeutic strategies with nanoparticles.
• Translation from laboratory to clinical practice is crucial for the future of breast cancer approaches.